Ceredex Value Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6,581,092
Closed -$122M 113
2020
Q2
$125M Buy
6,581,092
+1,460,567
+29% +$25.9M 1.86% 11
2020
Q1
$89.3M Buy
5,120,525
+1,171,225
+30% +$24.5M 1.53% 14
2019
Q4
$84.4M Buy
3,949,300
+53,150
+1% +$1.08M 0.97% 39
2019
Q3
$77.2M Buy
3,896,150
+1,600,950
+70% +$29.4M 0.91% 47
2019
Q2
$40.6M Sell
2,295,200
-236,200
-9% -$4.25M 0.49% 74
2019
Q1
$47.5M Sell
2,531,400
-400,550
-14% -$7.14M 0.58% 64
2018
Q4
$47.9M Sell
2,931,950
-1,316,600
-31% -$20.8M 0.64% 63
2018
Q3
$64.4M Sell
4,248,550
-458,200
-10% -$6.68M 0.72% 58
2018
Q2
$67.3M Sell
4,706,750
-333,927
-7% -$4.42M 0.77% 53
2018
Q1
$66.8M Buy
+5,040,677
New +$64.5M 0.79% 42

Other funds holding MPT

Ceredex Value Advisors's MPT Position: Q3 2020 in Review

Ceredex Value Advisors sold out of Medical Properties Trust (MPT) in Q3 2020, closing a stake of 6,581,092 shares — an estimated $122M sold.

Ceredex Value Advisors first reported a position in MPT in Q1 2018 and held it in 10 quarters. The position peaked at $125M in Q2 2020. 511 funds tracked by Wall St. Rank hold MPT as of Q3 2020.

  • Ceredex Value Advisors reported no remaining Medical Properties Trust position as of Q3 2020 after selling out during the quarter.
  • Ceredex Value Advisors sold 6,581,092 Medical Properties Trust shares in Q3 2020, an estimated $122M.
  • Ceredex Value Advisors first reported a position in Medical Properties Trust in Q1 2018 and held it in 10 quarters.
  • Ceredex Value Advisors's Medical Properties Trust position peaked at $125M in Q2 2020.
  • 511 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2020.

Based on Ceredex Value Advisors's 13F filing for Q3 2020, filed 9 Nov 2020.